Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 11, 2021, titled "Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Phosphate Gel USP, 1%".
Press Release Feb 11 2021
Filed with NSE ·
6ix hasn’t read this filing yet.
Glenmark Pharmaceuticals Limited on 6ix
Earlier from Glenmark Pharmaceuticals
- Press Release Feb 03 2021
- Press Release Jan 28 2021
- Press Release Dec 31 2020
- Press Release Dec 29 2020
- Press Release Dec 23 2020
Later from Glenmark Pharmaceuticals
- Press Release Feb 16 2021
- Press Release Feb 22 2021
- Press Release Feb 25 2021
- Press Release Mar 05 2021
- Press Release Mar 22 2021
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals